0001493152-20-006344.txt : 20200414
0001493152-20-006344.hdr.sgml : 20200414
20200414142832
ACCESSION NUMBER: 0001493152-20-006344
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20200414
DATE AS OF CHANGE: 20200414
EFFECTIVENESS DATE: 20200414
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akers Biosciences, Inc.
CENTRAL INDEX KEY: 0001321834
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-364932
FILM NUMBER: 20791054
BUSINESS ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
BUSINESS PHONE: 856-848-8698
MAIL ADDRESS:
STREET 1: 201 GROVE RD
CITY: THOROFARE
STATE: NJ
ZIP: 08086
FORMER COMPANY:
FORMER CONFORMED NAME: Akers Biosciences Inc
DATE OF NAME CHANGE: 20050325
D
1
primary_doc.xml
X0708
D
LIVE
0001321834
Akers Biosciences, Inc.
201 GROVE ROAD
THOROFARE
NJ
NEW JERSEY
08086
(856) 848-8698
NEW JERSEY
None
Akers Biosciences Inc
Corporation
true
Howard
Yeaton
201 Grove Road
Thorofare
NJ
NEW JERSEY
08086
Executive Officer
Interim Chief Financial Officer
Christopher
C.
Schreiber
201 Grove Road
Thorofare
NJ
NEW JERSEY
08086
Executive Officer
Director
Executive Chairman of the Board of Directors; Principal Executive Officer
Joshua
Silverman
201 Grove Road
Thorofare
NJ
NEW JERSEY
08086
Director
Bill
J.
White
201 Grove Road
Thorofare
NJ
NEW JERSEY
08086
Director
Robert
C.
Schroeder
201 Grove Road
Thorofare
NJ
NEW JERSEY
08086
Director
Other Health Care
Decline to Disclose
- 06b
false
2020-04-08
false
true
true
false
0
459998
459998
0
Represents the issuance to the placement agent of warrants to purchase up to 61,333 shares of common stock at an exercise price of $7.50/share in connection with a registered offering of common stock that closed on April 8, 2020.
false
1
0
0
0
false
Akers Biosciences, Inc.
/s/ Howard Yeaton
Howard Yeaton
Interim Chief Financial Officer
2020-04-14